Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Urinary Bladder Neoplasms × Watchful Waiting × Clear all

Status

Sponsor Class

Study Type

Interventional 4 Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 10 Neoplasms 9 Breast Neoplasms 8 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lung Neoplasms 3 Colonic Neoplasms 3 Thrombocythemia, Essential 2 Testicular Neoplasms 2 Stomach Neoplasms 2 Skin Diseases 2 Primary Myelofibrosis 2 Polycythemia Vera 2 Myeloproliferative Disorders 2 Melanoma 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Hodgkin Disease 2 Hematologic Diseases 2 Carcinoma, Renal Cell 2 Burkitt Lymphoma 2 Breast Neoplasms, Male 2 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Uveal Melanoma 1 Urinary Bladder Neoplasms 1

Interventions

Surveys and Questionnaires 7 Cystectomy 6 Neoadjuvant Therapy 4 Cystoscopy 4 Blood Specimen Collection 4 avelumab 2 Urinary Diversion 2 Surgical Procedures, Operative 2 Radiotherapy 2 Pioglitazone 2 Methods 2 Magnetic Resonance Spectroscopy 2 Interviews as Topic 2 Immunohistochemistry 2 Drug Therapy 2 Defecation 2 Biopsy 2 5-aminolevulinic acid hexyl ester 2 trastuzumab deruxtecan 1 sargramostim 1 pembrolizumab 1 erdafitinib 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 Watchful Waiting 1 Urinary Sediment Analysis 1 Specimen Handling 1 Remote Patient Monitoring 1 Registries 1 Radiosurgery 1 Radionuclide Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02676180 2023-12-08

DETECT I

University College, London

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡